Short course radiation therapy for elderly cancer patients. Evidences from the literature review

Critical Reviews in Oncology/Hematology

Volumn 45, Issue 3, 2003, Pages 305-311

  Donato, Vittorio ^a   Valeriani, Maurizio ^b   Zurlo, Alfredo ^c  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b SAN SALVATORE HOSPITAL   (Italy)

^c EORTC DATA CENTER   (Belgium)

Author keywords

Elderly cancer patients; Hypofractionated radiation therapy; Medical related diseases; Quality of life; Symptom relief

Indexed keywords

OXYGEN; TAMOXIFEN;

AGED; BLADDER DYSFUNCTION; BLADDER TUMOR; BRAIN TUMOR; BREAST TUMOR; CANCER CONTROL; CANCER PALLIATIVE THERAPY; CANCER RADIOTHERAPY; CLINICAL TRIAL; COLORECTAL CARCINOMA; GLIOMA; HEAD AND NECK CANCER; HUMAN; INTESTINE DISTENSION; LARYNX CARCINOMA; LIFE EXPECTANCY; LUNG TUMOR; MORBIDITY; PROSTATE TUMOR; RADIATION DOSE; REVIEW;

EID: 0037333890     PISSN: 10408428     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1040-8428(02)00082-3     Document Type: Review

References (64)

1. Zagonel V. Evolution of the clinical approach to the elderly patient with cancer. Rays. 24:(Suppl. 2):1999;67-72.
2. McKenna R.J. Clinical aspects of cancer in the elderly. Cancer. 74:1994;2107-2117.
3. Yancik R. Leading causes of cancer deaths in older persons. Rays. 24:(Suppl. 2):1999;10-16.
4. Fentiman L.S., Tirelli U., Monfardini S., et al. Cancer in the elderly: why so badly treated. Lancet. 335:1990;1020-1022.
5. Bergam L., Dekker G., Van Leeuven F., Huisman S.J., Van Dam F.S., Van Dongen J.A. The effect of age on treatment choice and survival in elderly breast cancer patients. Cancer. 67:1991;2227-2234.
6. Fentiman L.S. Treatment of cancer in the elderly. Br. J. Cancer. 64:1991;993-995.
7. Olmi P., Ausili-Cefaro G. Radiotherapy in the elderly: a multicentric prospective study on 2060 patients referred to 37 italian radiation therapy centers. Rays. 22:(Suppl. 1):1997;53-56.
8. Powell S., Cooke J., Parsons C. Radiation-induced brachial plexus injury: follow-up of two different fractionation schedules. Radiother. Oncol. 18:1990;213-220.
9. Turrisi A.T. The elderly cancer patient: radiotherapy issues. Rays. 24:(Suppl. 2):1999;17-21.
10. Donato V., Montagna A., Musio D., Cellini N. Radiotherapy in the symptomatic treatment of the oncological patients. Anticancer Res. 19:1999;3375-3382.
11. Balducci L., Beghè C. Advances in geriatric oncology. Rays. 24:(Suppl. 2):1999;22-25.
12. Cassel C.K. Money, medicine and metuselah. Mount Sinai J. Med. 65:1998;237-245.
13. Hulshof M.C., Koot R.W., Schimmel E.C., Dekker F., Bosch D.A., Gonzalez Gonzalez D. Prognostic factors in glioblastoma multiforme. Ten years experience of a single institution. Strahlenther Onkol. 177:2001;283-290.
14. Slotman B.J., Kralendonk J.H., van Alphen H.A., Kamphorst W., Karim A.B. Hypofractionated radiation therapy in patients with glioblastoma multiforme: results of treatment and impact of prognostic factors. Int. J. Radiat. Oncol. Biol. Phys. 34:1996;895-898.
15. Hercbergs A.A., Tadmor R., Findler G., Sahar A., Brenner H. Hypofractionated radiation therapy and concurrent cisplatin in malignant cerebral gliomas. Rapid palliation in low performance status patients. Cancer. 64:1989;816-820.
16. Hulshof M.C., Schimmel E.C., Andries Bosch D., Gonzalez Gonzalez D. Hypofractionation in glioblastoma multiforme. Radiother. Oncol. 54:2000;143-148.
17. DeAngelis L.M. Radiotherapy of the brain in elderly patients. Arbiter. Eur. J. Cancer. 36:2000;451-452.
18. Corry J., Smith J.G., Wirth A., et al. Primary central nervous system lymphoma: age and performance status are more important than treatment modality. Int. J. Radiat. Oncol. Biol. Phys. 41:1998;615.
19. Abrey L.E., DeAngelis L.M., Yaholom J. Long-term survival in primary CNS lymphoma. J. Clin. Oncol. 16:1998;859.
20. Blay J.Y., Conroy T., Chevreau C., et al. High-dose methotrexate for the treatment of primary cerebral lymphomas: analysis of survival and late neurologic toxicity in a retrospective series. J. Clin. Oncol. 16:1998;864.
21. Yancik R., Ries L.G., Yates I.W. Breast cancer in aging women. A population based study of contrasts in stage, surgery and survival. Cancer. 63:1989;976-981.
22. Fowble B. An assessment of treatment options for breast conservation in the elderly woman with early stage breast cancer. Int. J. Radiat. Oncol. Biol. Phys. 31:(4):1995;1015-1017.
23. Borger J., Kemperman H., Hart A., Peterse H., van Dongen J., Bartelink H. Risk factors in breast-conservation therapy. J. Clin. Oncol. 12:1994;653-660.
24. Bartelink H., Horiot J.H., Poortmans P.M., et al. Recurrence rates after treatment of breast cancer with standard radiotherapy with or without additional radiation. New Eng. J. Med. 345:2001;1378-1387.
25. Gajdos C., Tartter P.I., Bleiweiss I.J., Lopchinsky R.A., Bernstein J.L. The consequence of undertreating breast cancer in the elderly. J. Am. Coll. Surg. 192:2001;698-707.
26. Balducci L., Extermann M., Carreca I. Management of breast cancer in the older woman. Cancer Control. 8:2001;431-441.
27. Maher M., Campana F., Mosseri V., et al. Breast cancer in elderly women: a retrospective analysis of combined treatment with tamoxifen and once-weekly irradiation. Int. J. Radiat. Oncol. Biol. Phys. 31:(4):1995;783-789.
28. Allen C., Cox E.B., Manton K.J., Coen H.J. Breast cancer in the elderly; current patterns of care. Am. Geriatr. Soc. 34:1986;637-642.
29. Aapro M., Ausili Cefalo G., Nolè F., Pacini P. Carcinoma mammario. Argomenti di Oncologia. 20:1999;137-142.
30. Rostom A.Y., Pradhan D.G., White W.F. Once weekly irradiation in breast cancer. Int. J. Radiat. Oncol. Biol. Phys. 13:1987;551-555.
31. Baillet F., Housset M., Maylin C., et al. The use of a specific hypofractionated radiation therapy regimen versus classical fractionation in the treatment of breast cancer: a randomized study of 230 patients. Int. J. Radiat. Oncol. Biol. Phys. 19:(5):1990;1131-1133.
32. Baglan K.L., Martinez A.A., Frazier R.C., et al. The use of high-dose-rate brachytherapy alone after lumpectomy in patients with early-stage breast cancer treated with breast-conserving therapy. Int. J. Radiat. Oncol. Biol. Phys. 50:2001;1003-1011.
33. Veronesi U., Orecchia R., Luini A., et al. A preliminary report of intraoperative radiotherapy (IORT) in limited-stage breast cancers that are conservatively treated. Eur. J. Cancer. 37:2001;2178-2183.
34. Numico G., Russi E., Merlano M. Best supportive care in non-small cell lung cancer: is there a role for radiotherapy and chemotherapy. Lung Cancer. 32:(3):2001;213-226.
35. Donato V., Zurlo A., Bonfili P., et al. Hypofractionated radiation therapy for inoperable advanced stage non-small cell lung cancer. Tumori. 85:(3):1999;174-176.
36. Plataniotis G.A., Theofanopoulou M.A. Treatment of inoperable stage iii and iv non-small-cell lung cancer: the 'average' radiotherapist's point of view. Onkologie. 24:(4):2001;333-339.
37. Lupattelli M., Maranzano E., Bellavita R., et al. Short-course palliative radiotherapy in non-small-cell lung cancer: results of a prospective study. Am. J. Clin. Oncol. 23:(1):2000;89-93.
38. Slawson R.G., Salazar O., Poussin-Rosillo H., Amin P.P., Strohl R., Sewchand W. Once-a-week versus conventional daily radiation treatment for lung cancer: final report. Int. J. Radiat. Oncol. Biol. Phys. 15:(1):1988;61-68.
39. Bleehen NM, Girling DJ, Fayers DM, Aber VR, Stephens RJ. Report to the medical research council by its lung cancer working party (1991). Inoperable non-small-cell lung cancer (NSCLC): a medical research council randomised trial of palliative radiotherapy with two fractions or ten fractions, Br. J. Cancer 1991;63(2):265-70.
40. Bleehen NM, Girling DJ, Stephens RJ. On behalf of the Medical Research Council Lung Cancer Working Party (1992). Fayers PM, Aber VR, Stephens RJ. Report to the Medical Research Council by its Lung Cancer Working Party. A Medical Research Council (MRC) randomised trial of palliative radiotherapy with two fractions or a single fraction in patients with inoperable non-small-cell lung cancer (NSCLC) and poor performance status, Br. J. Cancer, 1992;65(6):934-41.
41. Slotman B.J., Njo K.H., de Jonge A., Meijer O.W.M., Karin F. Hypofractionated radiation therapy in unresectable stage III non-small cell lung cancer. Cancer. 72:(6):1993;1885-1893.
42. Appold S., Baumann M., Neidt F., Herrmann T. Ergebnisse der bestrahlung inoperabler nichtkleinzellinger bronchialkarzinome im stadium III mit 25 Gy in funf fraktionen. Strahlentherapie und Onkologie. 175:(6):1999;267-270.
43. Van Erps P., Van Den Weyngaert D., Denis L. Surgery or radiation: is there really a choice for early prostate cancer. Crit. Rev. Oncol. Hematol. 27:1998;11-27.
44. Hanks G.E. Progress in 3D conformal radiation treatment of prostate cancer. Acta Oncol. 38:(Suppl 13):1999;69-74.
45. Brenner D.J., Hall E.J. Fractionation and protraction for radiotherapy of prostate carcinoma. Int. J. Radiat. Oncol. Biol. Phys. 43:(3):1999;1095-1101.
46. Haustermans K.M., Hofland I., Van Poppel H. Cell kinetic measurements in prostate cancer. Int. J. Radiat. Oncol. Biol. Phys. 37:1997;1067-1070.
47. Fowler J., Chappell R., Ritter M. Is alpha/beta for prostate tumors really low. Int. J. Radiat. Oncol. Biol. Phys. 50:(4):2001;1021-1031.
48. Collins C.D., Lloyd-Davies R.W., Swan A.V. Radical external beam radiotherapy for localised carcinoma of the prostate using a hypofractionation technique. Clin. Oncol. 3:(3):1991;127-132.
49. Yancik R., Ries L.G. Cancer in the aged. An epidemiologic perspective on treatment issues. Cancer. 68:(Suppl 11):1991;2502-2510.
50. Sylvester R., Sternberg C. The role of adjuvant combination chemotherapy after cystectomy in locally advanced bladder cancer: what we do not know and why. Ann. Oncol. 11:2000;851-856.
51. Wijkstrom H., Nashund I., Ekman P. Short-term radiotherapy as palliative treatment in patients with transitional cell bladder cancer. Br. J. Urol. 67:1991;74-78.
52. Salminen E. Unconventional fractionation for palliative radiotherapy of urinary bladder cancer. A retrospective review of 94 patients. Acta Oncol. 31:1992;449-454.
53. Srinivasan V., Brown C.H., Turner A.G. A comparison of two radiotherapy regimens for the treatment of symptoms from advanced bladder cancer. Clin. Oncol. 6:1994;11-13.
54. Rostom A.Y., Tahir S., Gershuny A.R., Kandil A., Folkes A., White W.F. Once weekly irradiation for carcinoma of the bladder. Int. J. Radiat. Oncol. Biol. Phys. 35:(2):1996;289-292.
55. McLaren D.B., Morrey D., Mason M.D. Hypofractionated radiotherapy for muscle invasive bladder cancer in the elderly. Radiother. Oncol. 43:1997;171-174.
56. Jose C.C., Price A., Norman A., et al. Hypofractionated radiotherapy for patients with carcinoma of the bladder. Clin. Oncol. 11:1999;330-333.
57. Duchesne G.M., Bolger J.J., Griffiths G.O., et al. On behalf of the Medical Research Council Bladder Cancer Working Party. A randomized trial of hypofractionated schedules of palliative radiotherapy in the management of bladder carcinoma: results of medical research council trial BA09. Int. J. Radiat. Oncol. Biol. Phys. 47:(2):2000;379-388.
58. Barman L., Olmi P., Franchin G., et al. Carcinomi del distretto ORL. Argomenti di Oncologia. 20:1999;149-154.
59. Haffty B.G., Hurley R.A., Peters L.G. Carcinoma of the larynx treated with hypofractionated radiation and hyperbaric oxygen: long-term tumor control and complications. Int. J. Radiat. Oncol. Biol. Phys. 45:(1):1999;13-20.
60. Chin R., Fisher R.J., Smee R.I., Barton M.B. Oropharingeal cancer in the elderly. Int. J. Radiat. Oncol. Biol. Phys. 32:(4):1995;1007-1016.
61. Suwinski R., Pilecki B., Skladowski K., et al. Sequential combination of radio-chemotherapy (5-fluorouracil, cis-platinum and irradiation) in the management of locally advanced head and neck cancers. Neoplasma. 43:1996;37-41.
62. Farniok K.E., Levitt S.H. The role of radiation therapy in the treatment of colorectal cancer. Cancer. 74:(7):1994;2154-2159.
63. Meoz R.T., Spanos W.J., Doss L. Misonidazole combined with large-fraction pelvic irradiation in the treatment of patients with advanced pelvic in the treatment of patients with advanced pelvic malignancies: preliminary report of an ongoing RTOG phase I-II study. Am. J. Clin. Oncol. 6:1983;417.
64. Abbatucci L.S., Boulier N., Laforge T., Lozier J.C. Radiation therapy of skin carcinomas: Results of hypofractionated irradiation schedule in 675 cases followed more than 2 years. Radiother. Oncol. 14:1989;113-119.